Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 20, 2009

High Throughput Genomics and Roche Join Forces for Advanced Gene-Expression Analysis Solution

  • High Throughput Genomics (HTG) is supplementing its service capabilities through a supply agreement with Roche Nimblegen. The firm will provide HTG with high density, multiplex DNA microarray slides for advanced gene-expression analysis.

    HTG will apply its quantitative nuclease protection assay (qNPA) process to the microarrays to enable researchers to quickly and efficiently measure the gene-expression levels in a variety of sample types. Sample preparation using qNPA technology allows for a simpler, more cost-effective workflow versus traditional labeling methods, according to HTG. The Roche NimbleGen multiplex technology offers a cost-effective high-density microarray providing in-depth gene-expression information, the company adds.



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »